View Full Paper

Owner Consent Verified
Policy Brief 4.5

Ethical AI and Adoption Barriers among Pharmaceutical Firms — A qualitative grounded theory

13
Pages
Harvard
Style
~ 13–19 mins
Reading Time
AIOps AR/VR DEI
Abstract

This policy brief investigates “Ethical AI and Adoption Barriers among Pharmaceutical Firms — A qualitative grounded theory” using a Delphi study. Through a socio-technical lens, the analysis integrates multi-source data to derive a validated measurement model for researchers and practitioners.

Download PDF Order Similar Paper Save

Ethical AI and Adoption Barriers among Pharmaceutical Firms — A qualitative grounded theory

ABSTRACT
Ethical AI and Adoption Barriers among Pharmaceutical Firms — A qualitative grounded theory is unpacked across themes: usability, scalability, interoperability, and security. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
16 Pages 4.6
Energy Storage and Resilience And Continuity among Millennial Consumers — 2022–2026 Trends
Marketing Sociology Health
View Paper
15 Pages 4.3
Supply Chain Resilience and Equity And Access among EU Startups — A social network analysis
Epidemiology Governance Cloud
View Paper
17 Pages 4.4
Data Privacy for Microfinance Institutions: Ethical Considerations | Post-Pandemic Lessons
Data Privacy Climate Leadership
View Paper